These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 200493)

  • 21. Phosphoinositide hydrolysis and insulin secretion in response to glucose stimulation are impaired in isolated rat islets by prolonged exposure to the sulfonylurea tolbutamide.
    Zawalich WS
    Endocrinology; 1989 Jul; 125(1):281-6. PubMed ID: 2544404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucagon secretion from the isolated perfused rat pancreas: influenced by the glucose-, tolbutamide- and pancreozymin-mediated release of pancreatic insulin.
    Fussgänger RD; Goberna R; Laube H; Schröder KE; Straub K; Pfeiffer EF
    Isr J Med Sci; 1972 Jun; 8(6):768-9. PubMed ID: 4559419
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies on kinetics of insulin secretion in perifused pancreatic islets of hamster. II. An inhibitory effect of sulfonylureas on a subsequent glucose-stimulated insulin secretion].
    Kikuchi M
    Fukuoka Igaku Zasshi; 1987 Feb; 78(2):46-54. PubMed ID: 3556363
    [No Abstract]   [Full Text] [Related]  

  • 24. Uptake of glibornuride by microdissected pancreatic islets.
    Täljedal IB
    Horm Res; 1974; 5(4):211-6. PubMed ID: 4210148
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute and chronic effects of sulfonylurea drugs on pancreatic islet function in man.
    Pfeifer MA; Halter JB; Judzewitsch RG; Beard JC; Best JD; Ward WK; Porte D
    Diabetes Care; 1984; 7 Suppl 1():25-34. PubMed ID: 6376026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of sulfonylureas on the secretion of pancreatic immunoreactive glucagon and enteric glucagon-like immunoreactivity.
    Crockford PM; Powell P; Addah SA
    Can J Physiol Pharmacol; 1973 Dec; 51(12):990-2. PubMed ID: 4204715
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of sulfonylureas on calcium uptake and insulin secretion by islets of Langerhans.
    Malaisse WJ; Mahy M; Malaisse-Lagae F
    Arch Int Pharmacodyn Ther; 1971 Jul; 192(1):205-7. PubMed ID: 4937349
    [No Abstract]   [Full Text] [Related]  

  • 28. Dual mechanism of the potentiation by glucose of insulin secretion induced by arginine and tolbutamide in mouse islets.
    Ishiyama N; Ravier MA; Henquin JC
    Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E540-9. PubMed ID: 16249257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of insulin secretion and its modulation by sulfonylureas.
    Panten U
    Contrib Nephrol; 1989; 73():16-21; discussion 22-3. PubMed ID: 2689091
    [No Abstract]   [Full Text] [Related]  

  • 30. The biosynthesis and secretion of insulin.
    Taylor KW
    Clin Endocrinol Metab; 1972 Nov; 1(3):601-22. PubMed ID: 4359227
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of SPC 703, a new sulfonylurea derivative, on the secretion and biosynthesis of insulin by isolated pancreatic islets in the rat].
    Wójcikowski C; Boreysza A; Dominiak K; Arendarczyk W; Gembal M
    Endokrynol Pol; 1987; 38(2):169-78. PubMed ID: 3325281
    [No Abstract]   [Full Text] [Related]  

  • 32. Glipizide: experimental study and comparison with other sulfonylureas.
    Loubatieres-Mariani MM
    Acta Endocrinol Suppl (Copenh); 1980; 239():26-32. PubMed ID: 6776761
    [No Abstract]   [Full Text] [Related]  

  • 33. Arginine stimulated glucagon and insulin secretion by islets of Langerhans of pregnant and lactating rats.
    Moes H; Schuiling GA; Koiter TR
    Horm Metab Res; 1993 May; 25(5):246-9. PubMed ID: 8330856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The role of cyclic AMP in the control of insulin secretion (author's transl)].
    Cerasi E; Grill V
    MMW Munch Med Wochenschr; 1977 Sep; 119(38):1229-36. PubMed ID: 198651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on insulin secretion in vitro from isolated islets of the rat pancreas.
    Lacy PE; Young DA; Fink CJ
    Endocrinology; 1968 Dec; 83(6):1155-61. PubMed ID: 4301830
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term actions of sulfonylureas on (Pro-) insulin biosynthesis and secretion. III. Functional state of isolated pancreatic rat islets after culture in the presence of tolbutamide and glibenclamide.
    Gonnermann B; Gustson D; Schatz H
    Horm Metab Res; 1981 Jul; 13(7):411-2. PubMed ID: 6792024
    [No Abstract]   [Full Text] [Related]  

  • 37. Control of glucagon secretion by nutrients in vitro.
    Matschinsky FM; Pagliara AS
    Metabolism; 1976 Nov; 25(11 Suppl 1):1435-6. PubMed ID: 185497
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of transglutaminase by hypoglycaemic sulphonylureas in pancreatic islets and its possible relevance to insulin release.
    Gomis R; Mathias PC; Lebrun P; Malaisse-Lagae F; Sener A; Malaisse WJ
    Res Commun Chem Pathol Pharmacol; 1984 Dec; 46(3):331-49. PubMed ID: 6151221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the cationic and secretory response of pancreatic islets to gliclazide and/or potassium.
    Mathias PC; Billaudel B; Malaisse WJ
    Res Commun Chem Pathol Pharmacol; 1983 Dec; 42(3):389-400. PubMed ID: 6320319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glyburide and tolbutamide induce desensitization of insulin release in rat pancreatic islets by different mechanisms.
    Rabuazzo AM; Buscema M; Vinci C; Caltabiano V; Vetri M; Forte F; Vigneri R; Purrello F
    Endocrinology; 1992 Oct; 131(4):1815-20. PubMed ID: 1396327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.